Lumibird Medical Launches Nd:YAG Laser Capsulo

Lumibird Group, the parent company of Quantel Medical, announced the launch of the Capsulo Nd:YAG laser. Lumibird says the device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments.

“Capsulo is built with exclusive high-quality optics delivering pristine clarity of view into the anterior and posterior segments of the eye. Advanced illumination with a variable-height light tower offers dual illumination angles of 16° and 7.5° for anterior and posterior laser applications," said Matthew Metcalfe, Anterior Segment Laser Product Manager at Lumibird Medical.

The Capsulo Nd:YAG laser can be paired with the Quantel Medical Vitra 2 MultiSpot photocoagulating laser, also from Lumibird Medical, combining pan-retinal photocoagulation functionality through a single slit lamp.

“Capsulo, when combined with the Vitra 2 photocoagulator, offers an ideal all-in one laser platform, and we are extremely proud to provide this highly versatile solution into the hands of discerning ophthalmologists," said Jean-Marc Gendre, CEO Lumibird Medical.

The Capsulo features optics optimized for enhanced viewing of the anterior and posterior segments; advanced illumination with a variable light tower height offering 2 different illumination angles; and a new Nd:YAG cavity. The device also has a full touch screen control.

Delegates attending The SFO congress in Paris, May 7-9, 2022, will have the opportunity to see the Capsulo laser on the Lumibird Medical booth #F9. 

The Capsulo laser is CE Marked and available for sale now in the EU. It is not yet approved in the United States. FDA approval is pending.